Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
Xiehui Chen, Weichao Huang, Aimei Sun, et al.
Thrombosis Journal (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Risk of Intracranial Hemorrhage Associated With Direct Oral Anticoagulation vs Antiplatelet Therapy
Mark Coyle, Amy Lynch, M Higgins, et al.
JAMA Network Open (2024) Vol. 7, Iss. 12, pp. e2449017-e2449017
Open Access | Times Cited: 5
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
Zhu Luo, Jie Wang, Zhuolu Niu, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1503-1514
Open Access
Risk of Spontaneous Intracerebral Hemorrhage Associated with NOACs Compared with Aspirin and Warfarin: A Long-Term Single Hospital Follow-Up Study
Yu‐Wen Cheng, Cai-Sin Yao, Yang‐Yi Chen, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 246, pp. 108561-108561
Closed Access | Times Cited: 1
Impact of bleeding event for new cancer diagnosis in patients with antiplatelet therapy after percutaneous coronary intervention
Yuya Sakuma, Takeshi Shimizu, Yuta Kurosawa, et al.
Journal of Cardiology (2023) Vol. 82, Iss. 6, pp. 460-466
Closed Access | Times Cited: 2
Preventive effect of aspirin on peripherally inserted central catheter-related vein thrombosis in patients with malignant tumors
Caiyan Yu, Shaohua Sun, Xiuqing Shi, et al.
Journal of Vascular Nursing (2023) Vol. 41, Iss. 4, pp. 153-157
Closed Access | Times Cited: 2
A Combination of Ex Vivo and In Vivo Strategies for Evaluating How Much New Oral Anticoagulants Exacerbate Experimental Intracerebral Bleeding
Paulo A.S. Mourão, Roberto J. C. Fonseca, Juliana Ribeiro Pinheiro Ferreira, et al.
TH Open (2023) Vol. 07, Iss. 03, pp. e195-e205
Open Access | Times Cited: 1
Dual-pathway inhibition in patients with chronic limb-threatening ischemia requiring reintervention for infrapopliteal occlusions
Burak Teymen, Mehmet Emin Öner, Yiğit Erdağ
Heart and Vessels (2024) Vol. 39, Iss. 9, pp. 771-777
Closed Access
Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19
X. Shen, Eryue Qiu, Zhao Liu, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 4, pp. 341-348
Open Access
Assays for Monitoring Apixaban and Rivaroxaban in Emergency Settings, State-of-the-Art Routine Analysis, and Volumetric Absorptive Microsamples Deliver Discordant Results
Adrienne Fehér, István Vincze, James Rudge, et al.
Diagnostics (2024) Vol. 14, Iss. 17, pp. 1939-1939
Open Access
Antithrombotic but not anticoagulant activity of the thrombin‐binding RNA aptamer Apta‐1
Luiza Jedlina, Geena V. Paramel, Svetlana Soboleva, et al.
British Journal of Pharmacology (2024)
Closed Access
Oral anticoagulation therapy in the treatment of pulmonary thromboembolism
Maja Omčikus, Ivan Milivojević
Galenika Medical Journal (2023) Vol. 2, Iss. 5, pp. 62-66
Closed Access
Page 1

Scroll to top